General Information of Drug (ID: DMYXD6A)

Drug Name
RWJ-58259 Drug Info
Synonyms RWJ-58259; CHEMBL7642; SCHEMBL14090275; BDBM50098215; LS-30985
Indication
Disease Entry ICD 11 Status REF
Artery stenosis BD52 Terminated [1]
Cross-matching ID
PubChem CID
9832212
TTD Drug ID
DMYXD6A

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Vorapaxar DMA16BR Myocardial infarction BA41-BA43 Approved [2]
E5555 DMQERC6 Acute coronary syndrome BA41 Phase 2 [3]
PZ-128 DMU5H3A Peripheral arterial occlusive disorder BD4Z Phase 2 [4]
FR-171113 DMIQB9E Thrombosis DB61-GB90 Terminated [5]
SCH-602539 DMRDM9S Arteriosclerosis BD40 Investigative [6]
RWJ-56110 DME07AN Discovery agent N.A. Investigative [7]
SCH-205831 DM584T6 Thrombosis DB61-GB90 Investigative [8]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Proteinase activated receptor 1 (F2R) TTL935N PAR1_HUMAN Modulator [1]

References

1 RWJ-58259: a selective antagonist of protease activated receptor-1. Cardiovasc Drug Rev. 2003 Winter;21(4):313-26.
2 In Process Citation. Pharm Unserer Zeit. 2009;38(4):320-8.
3 Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin-Acute Coronary Syndromes Trial. Circulation. 2011 May 3;123(17):1843-53.
4 PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study. Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2990-3003.
5 In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. Eur J Pharmacol. 1999 Nov 19;384(2-3):197-202.
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 347).
7 Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12257-62.
8 Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4509-13.